Effect of acupuncture pretreatment on clinical pregnancy rate in women with diminished ovarian reserve undergoing IVF-ET: study protocol for a multicenter randomized controlled trial

Read full text
Authors: Xin Liu, Chenchen Su, Junmin Li, Li Chen, Qinhua Zhang, Yan Sun, Jinbang Xu, C L Zhang, Xinjie Cheng, Xuemei Li, Huisheng Yang, Yicong Xie
+18 more Jie Yang, Na Zhu, Weiying Lu, Tongsheng Su, Wei Shang, Qun Lu, Li Yang, Jiashan Li, Hang Tian, Lingyu Qi, Qiwei Xiao, Weixin Li, Feng Gao, Xiaoyan Wang, Pengfei Du, Dongxue An, Huanfang Xu, YiGong Fang
Cited by: 0
References: 27

Abstract

Introduction: fertilization and embryo transfer (IVF-ET). Acupuncture maybe effective for DOR, but current evidence remains limited and inconclusive. Methods and analysis: This study is a multicenter, randomized, placebo-controlled trial conducted on a large scale. A total of 300 women with DOR preparing for IVF-ET will be randomized 1:1 to acupuncture or placebo acupuncture. Interventions will be administered from the second menstrual cycle preceding the IVF cycle until the day of oocyte retrieval. The primary outcome is the clinical pregnancy rate (CPR) following the first embryo transfer. Secondary outcomes include various IVF-ET indicators, such as the number of follicles ≥ 14 mm, estradiol (E2) levels, and endometrial thickness on the day of human chorionic gonadotropin (hCG) administration; the number of retrieved oocytes, metaphase II (MII) oocytes, and two pronuclei (2PN) fertilizations; as well as the rates of 2PN fertilization, available embryos, high-quality embryos, implantation, cycle cancellation, biochemical pregnancy, pregnancy loss, sustained pregnancy, and live birth. Additionally, ovarian reserve indicators-including antral follicle count (AFC), basal serum levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), and E2, and anti-Müllerian hormone (AMH)-along with scores from the Self-Rating Anxiety Scale (SAS) will also be evaluated. Ethics and dissemination: The trial has been approved by the ethics committees of all participating centers. The results will be disseminated in academic journals. Clinical Trial Registration: http://itmctr.ccebtcm.org.cn/, identifier ID: ITMCTR2024000021.

Fields of Study & Subjects

Acupuncture Treatment Research Studies Reproductive Health and Technologies Reproductive Biology and Fertility

Publication details

Journal / source
Frontiers in Endocrinology
Volume
17
Pages
1723278–1723278
Publication date
5 February 2026
Language
EN